WVE Q2 2020 Earnings — Wave Life Sciences Ltd. Revenue & Financial Results | Market Cap Arena

WVEWave Life Sciences Ltd.

$3B

Q2 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3M-60.3% YoY

Gross Profit

-$28M-939.9% margin

Operating Income

-$39M-1277.0% margin

Net Income

-$41M-1338.9% margin

EPS (Diluted)

$-1.15

QoQ Revenue Growth

-27.3%

Cash Flow

Operating Cash Flow

-$38M

Free Cash Flow

-$38M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$204M

Total Liabilities

$201M

Stockholders' Equity

$3M

Cash & Equivalents

$94M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$8M	-60.3%
Gross Profit	-$28M	-$34M	+16.3%
Operating Income	-$39M	-$46M	+15.3%
Net Income	-$41M	-$42M	+3.4%